Form 8-K - Current report:
SEC Accession No. 0001420720-26-000014
Filing Date
2026-08-04
Accepted
2026-08-04 07:05:35
Documents
14
Period of Report
2026-07-31
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ibio-20260722x8k.htm   iXBRL 8-K 42454
2 EX-10.1 ibio-20260722xex10d1.htm EX-10.1 96660
3 EX-99.1 ibio-20260722xex99d1.htm EX-99.1 12272
  Complete submission text file 0001420720-26-000014.txt   287926

Data Files

Seq Description Document Type Size
4 EX-101.SCH ibio-20260722.xsd EX-101.SCH 3502
5 EX-101.DEF ibio-20260722_def.xml EX-101.DEF 2848
6 EX-101.LAB ibio-20260722_lab.xml EX-101.LAB 14623
7 EX-101.PRE ibio-20260722_pre.xml EX-101.PRE 9545
18 EXTRACTED XBRL INSTANCE DOCUMENT ibio-20260722x8k_htm.xml XML 4082
Mailing Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737
Business Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737 302 355-0650
iBio, Inc. (Filer) CIK: 0001420720 (see all company filings)

EIN.: 262797813 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-35023 | Film No.: 261235417
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)